AIS LIFE
Aerobiological Information Systems and allergic respiratory disease management
AIS Life LIFE 13 ENV/IT/001 107
European Project
AIS LIFE
The project AIS LIFE project – Aerobiological Information Systems and allergic respiratory disease management has been approved for funding within the LIFE+ programme (2007-2013).
The Coordinator is from the University of Florence – Department of Agri-food Production and Environmental Sciences. With partners from 3 EU countries (Italy, France, Austria) the project’s overall aim is to develop the information base for policy on environment and health, in terms of improved management of pollen-related allergic respiratory diseases.
Any question ?
AIS Life objective
The AIS project proposes a series of realistic objectives to be achieved within its proposed time frame and means, which work towards to overall project aim: to develop the information base for policy on environment and health, in terms of improved management of pollen-related allergic respiratory diseases.
AIS Life innovation in process and methods
Well established methods for assessment of exposure to pollen and ultrafine particulate will be integrated for the first time. The effects of integrated information on QoL, symptoms,
objective parameters and medication use will be evaluated. If one type of information or a combination of methods proves superior, a new pollen/pollutants information processing and dissemination will be available and applicable to any country. The rigorous design of the study can be applied to other types of environmental information systems aiming to reduce risks for human health.
AIS Life technological innovation
Technology has improved pollen forecasting and dissemination of pollen information. However, clinical impact of such information is still debated. AIS compares, for the first time, a high-tech system (web-based symptoms diary + smartphone application) and a lowtech one (aerobiological and air pollutants forecasts and medical recommendations) in terms of effectiveness in patients affected by allergic respiratory diseases. The system will include information on ultrafine particles, which represent a technological innovation in this field.
AIS Life economic and business innovation
Although several applications for smartphone have been developed for information about environmental hazards for health in, none has been tested and validated for patients affected by allergic respiratory diseases. Once proved effective both from a clinical and a costeffectiveness point of view, the application will be further developed and disseminated, thus paving the way for new, permanent information systems and a continuous innovation of the model. With limited short-term mitigation measures against pollen exposure, facilitation of behavioural adaptation and preemptive medication of sensitive population is the most-important goal.